(Q37784315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Heparin as an inhibitor of cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Lubor Borsig

series ordinal

1

1 reference

23 August 2017

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

Progress in Molecular Biology and Translational Science

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

335-349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

How I treat venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

The effect of low molecular weight heparin on survival in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Impact of venous thromboembolism and anticoagulation on cancer and cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Mechanisms of heparin induced anti-cancer activity in experimental cancer models

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Comparison of metastatic cell lines derived from a murine mammary tumour, and reduction of metastasis by heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

An update on heparins at the beginning of the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Actions of heparin that may affect the malignant process

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Generic low-molecular-weight heparins: some practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Novel drug development opportunities for heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Antimetastatic effect of tinzaparin, a low-molecular-weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Low-molecular-weight heparin and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

The impact of heparanese and heparin on cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Heparanase, heparin and the coagulation system in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Non-anticoagulant heparins and inhibition of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Heparanase promotes the spontaneous metastasis of myeloma cells to bone

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Selectin-carbohydrate interactions during inflammation and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

The role of selectins in inflammation and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Selectin ligands, leukocyte trafficking, and fucosyltransferase genes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

CD62/P-selectin recognition of myeloid and tumor cell sulfatides

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Selectin ligands: will the real ones please stand up?

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Perspectives on the significance of altered glycosylation of glycoproteins in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Mucin glycoproteins in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Immunohistochemical expression of the sialyl Lewis x antigen on gastric cancer cells correlates with the presence of liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Tumor metastasis: mechanistic insights and clinical challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Cancer metastasis: building a framework

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

P-selectin deficiency attenuates tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Selectins as mediators of lung metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Human neutrophils facilitate tumor cell transendothelial migration.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Redirection of tumor metastasis by expression of E-selectin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993014-7

7 January 2021

10.1016/S1877-1173(10)93014-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807651%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference